Vantage MedTech
Peter Selinsky is a skilled engineer currently serving as a System Engineer at Vantage MedTech since May 2023. Prior to this role, Peter worked as a Reliability Engineer at Philips from October 2022 to April 2023. Peter's experience includes significant research as a Biomedical Researcher at the Artificial Heart and Cardiovascular Fluid Dynamics Laboratory, where Peter conducted fluid dynamics analyses using particle image velocimetry and developed protocols for silicone replicas for blood flow visualization. Additionally, Peter served as a Biomedical Department Grader at Penn State University, providing assessments for undergraduate courses and supporting students during office hours. Early career experience includes an internship at Nittany Laser Technologies, where Peter learned and applied advanced manufacturing processes. Peter holds a Master of Science in Biomedical Engineering from the J. Jeffrey and Ann Marie Fox Graduate School at Penn State and dual Bachelor of Science degrees in Biomedical Engineering and Mechanical Engineering from Penn State University.
This person is not in any teams
Vantage MedTech
Vantage MedTech provides comprehensive design and manufacturing services, supporting the advancement of medical technologies from concept through to product realization. Partnering with the world’s most innovative MedTech start-ups and large medical device companies, we offer feasibility support, product development and prototyping, new product development, clinical and commercial manufacturing, and after-market services to support every phase of the product life cycle. Our clients can leverage our proprietary Advantage Platforms™, accelerating product development timelines. Our manufacturing approach is structured to serve the changing needs of our clients, supporting small-quantity clinical or First-in-Human builds and can scale to accommodate full launch quantities. Vantage MedTech has facilities in Moonachie, New Jersey and Lenexa, Kansas. Visit www.vantagemedtech.com for more information.